Qprotyn Inc.

Qprotyn is a Delaware biotech corporation that is bringing to market a patented viscosity-reduction, formulation platform called HILOPRO® . HILOPRO® enables high-dose, large molecule monoclonal antibodies to move from IV administration to subcutaneous (SubQ) injection. Using only two GRAS excipients, HILOPRO™ delivers low-volume formulations with concentrations greater than 225mg/mL while ma...